RXST(RxSight, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $22.59M | $49.01M | $89.08M | $139.93M | $134.48M |
| 毛利润 | $4.52M | $21.33M | $53.77M | $98.94M | $103.01M |
| 营业利润 | −$52.79M | −$63.32M | −$50.09M | −$36.86M | −$48.19M |
| 净利润 | −$48.69M | −$66.76M | −$48.61M | −$27.45M | −$38.94M |
| 经营现金流 | −$44.71M | −$58.85M | −$41.59M | −$16.95M | −$15.51M |
| 自由现金流 | −$46.65M | −$61.24M | −$46.41M | −$22.39M | −$19.34M |
| 摊薄每股收益 | $-3.57 | $-2.41 | $-1.41 | $-0.71 | $-0.95 |